"Excess deaths at weekends were reported for heart attack patients a decade ago and we wanted to see if the situation had improved," said Giovanni Malanchini from the University of Milan.
"We also looked at whether there were differences by age or sex," said Malanchini, lead author of the study.
The study included all 80,391 patients with an acute coronary syndrome admitted to a hospital in the Lombardy region of Italy for less than 20 days between January 2010 and December 2014.
When all patients were analysed, the researchers found a 13 per cent higher risk of death in those admitted at weekends compared to weekdays.
"We analysed data from the Milan area, which provides some of the best treatment for heart patients in Italy. Yet even here we are not delivering the best care every day of the week," Malanchini said.
The researchers then analysed outcome according to different age cut-offs (under 45, 55, 65, 75, and over 75 years).
Patients under 45 had a more than two-fold risk of dying at the weekend, while the excess risk in the over-75s was just 5 per cent.
"This is a new finding, that younger heart attack patients are particularly vulnerable to the excess mortality linked to weekend admissions," said Federico Lombardi, professor at University of Milan.
Men and women were then analysed separately. The researchers found that men admitted on any day of the week with an acute coronary syndrome had a 15 per cent lower risk of death than women.
The observational study did not examine the reasons for the excess mortality at weekends, and the causes are likely multi-factorial, researchers said.
However, they said that patients admitted at weekends may have to wait longer for reperfusion therapy to open occluded arteries and restore blood flow.
"The delay in reperfusion during weekends may be more important in younger patients," said Malanchini.
"This is usually their first acute coronary syndrome and they are not receiving aspirin, drugs to lower cholesterol (statins), or drugs to lower blood pressure (angiotensin converting enzyme inhibitors and beta-blockers). This could make them more vulnerable," Lombardi said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
